【摘要】：目的:觀察通腑潤腸湯高位保留灌腸治療慢傳輸型便秘(STC)模型大鼠的效果及對結腸Cajal間質細胞(ICC)、血管活性腸肽(VIP)的影響,探討通腑潤腸湯高位保留灌腸治療STC的效果及作用機制。方法:將60只SD大鼠隨機分為A組(空白對照組)、B組(便秘模型組)、C組(莫沙必利組)、D組(中藥高位保留灌腸低劑量組)、E組(中藥高位保留灌腸中劑量組)、F組(中藥高位保留灌腸高劑量組)。造模期間用復方地芬諾酯對B組、C組、D組、E組、F組灌胃造模,用生理鹽水對A組灌胃。造模成功后,A組、B組用生理鹽水灌胃,剩余各組用對應藥物治療。觀察各組大鼠造模前、造模成功后及治療完成后的一般情況、24h內的糞便粒數(shù)及糞便的含水率,治療結束后檢測SD大鼠的結腸炭末推進率、血清VIP濃度、結腸ICC數(shù)量。結果:(1)在排便粒數(shù)上,C、D、E、F組和B組比較的p值均為0.000,P0.05;E組和C組、D組比較的p值均為0.001,p0.05;F組和C組、D組比較的p值均為0.001,p0.05;C組、D組比較比較的p值0.930,p0.05;E組、F組比較的p值為0.784,p0.05。(2)在糞便含水率上,B組和C組比較的p值為0.820,p0.05;B和D、E、F組比較的p值為依次為0.002、0.001、0.001,p0.05;D組和E、F組比較的p值依次為0.721、0.752,p0.05;E組和F組比較的p值為0.960,p0.05;(3)在結腸炭末推進率上,B組和C、D、E、F組比較的p值都為0.000,p0.05;E組和C、D組比較的p值都為0.000,p0.05;F組和C、D組比較的p值都為0.000,p0.05;C組和D組比較的p值為0.710,p0.05;E組和F組比較的p值為0.964,p0.05。(4)在影響VIP濃度上,C、D、E、F組和B組比較的p值都依次為0.000、0.001、0.000、0.000,P0.05;而C組和D、E、F組比較的p值依次為0.593、0.954、0.643;D組和E、F組比較的p值依次為0.642、0.933;E組和F組比較的p值為0.694,p0.05。(5)在影響ICC數(shù)量上,C、D組與B組比較的p值依次為0.311、0.106,P0.05;E、F組與B組比較的p值依次0.006、0.020,p0.05。結論:通腑潤腸湯高位保留灌腸通過增加結腸ICC數(shù)量、血清VIP濃度來增加排便量、提高糞便含水率、促進腸道傳輸以改善便秘癥狀。通腑潤腸湯高位保留灌腸中、高劑量療效相當,均較通腑潤腸湯高位保留灌腸低劑量及莫沙必利治療效果好。
[Abstract]:Objective: to observe the effect of Tongfu Runchang decoction high position retention enema on slow transit constipation (STC) model rats and the effect of Tongfu Runchang decoction on (ICC), vasoactive intestinal peptide (VIP) in interstitial cells of colon Cajal. To explore the effect and mechanism of Tongfu Runchang decoction (Tongfu Runchang decoction) in the treatment of STC with high retention enema. Methods: sixty Sprague-Dawley rats were randomly divided into two groups: group A (control group), group B (constipation model group), group C (mosapride group), group D (low dose group of high retention enema of traditional Chinese medicine) and group E (middle dose group of high retention enema of traditional Chinese medicine). Chinese medicine high retention enema high dose group). During the course of modeling, compound diphenoxylate was used to make models in group B, group C, group D, group C, group E, group F, and group A, with normal saline. The rats in group A were given normal saline and the rest were treated with corresponding drugs. The number of fecal particles and the fecal moisture content were observed before, after and after treatment. The colon carbon propelling rate, serum VIP concentration and colonic ICC content of SD rats were measured after treatment. Results: (1) the p values of group F and group B were both 0.000, P0.05E and C, respectively. The p values of group F and group C were both 0.001p0.05F and 0.001p0.05C, respectively. The p values of group D and group D were 0.930 and 0.05g respectively. (2) the p values of group B and group C were 0.820, p0.05B and group F, respectively. The p values of group D and group E were 0.7210.752p0.05E and 0.960p0.05E, respectively; (3) the rate of propelling of colon carbon in group B and group C were 0.960p0.05; (3) in group B and group C, the p values of group B and group C were 0.960p0.05; (3) the p values of group B and group C were respectively 0.7210.752p0.05E and 0.960p0.05e; (3) the p values of group B and group C were higher than those of group F and group B (P = 0.960p0.05) respectively; (3) the p values of group B and group C were 0.960p0.05 respectively. The p values of group E and C D were both 0.000g / d and 0.000g / d, respectively. The p values of group C and group D were both 0.000g / g and 0.000g / d, respectively. The p values of group C and group D were 0.710g / p0.05E and 0.964g / 0.05p respectively. (4) the difference of VIP concentration between group F and group B was found to be higher than that of group C and group D (P = 0.605), respectively. (4) the difference between group C and group B was as follows: (1) the difference between group C and group D was as follows: (1) the difference between group C and group D was as follows: (1) the difference between group C and group B was significant. The p values of group C and group D were 0.593.0.954 and 0.643N, respectively, and the p values of group E and group F were 0.642n0.9033 and 0.694p0.05 respectively. (5) the p values of group D and group B were 0.3110.106and 0.3110.106p respectively. (5) in terms of the number of ICC, the p values of group D and group B were 0.3110.106p 0.05e and 0.694p 0.05, respectively. (5) the p values of group C and group B were 0.3110.106p 0.05p 0.055.The p values of group E and group F were 0.694p0.05, respectively. (5) the p values of group C and group B were 0.3110.106p 0.05 and 0.694p0.05 respectively. The p value of the group was 0.006, 0.020, p0.05, respectively. Conclusion: Tongfu Runchang decoction high retention enema can increase fecal excretion, increase fecal moisture and improve intestinal transport to improve constipation symptoms by increasing the number of colon ICC and serum VIP concentration. In the high retention enema of Tongfu Runchang decoction, the effect of high dose retention enema was equal, which was better than that of Tongfu Runchang decoction high retention enema low dose and mosapride.
【學位授予單位】：川北醫(yī)學院
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R574.62

【參考文獻】

相關期刊論文 前10條

1 黃小麗;陳琳;陳晨;張蕾;劉婉;胡榮;孔桂美;卜平;董小耘;王雋;;3種便秘模型的比較研究[J];四川動物;2015年01期

2 楊稀;楊勇軍;劉仕鴻;李鐘艷;劉暢;;中西藥促胃腸動力藥治療慢傳輸型便秘的臨床研究進展[J];川北醫(yī)學院學報;2014年06期

3 夏旭婷;樊俊陽;易健;劉富林;;Cajal間質細胞在慢傳輸型便秘發(fā)病機制中的作用[J];湖南中醫(yī)雜志;2014年10期

4 韓玉娜;朱葉珊;雷淼娜;張亞芳;聶欣寧;;改良愈瘍方對潰瘍性結腸炎模型小鼠腸道菌群的影響[J];河北中醫(yī);2014年05期

5 吳霜;程瀅瑞;周錦勇;吳本升;陳玉根;楊柏霖;;洛哌丁胺構建大鼠便秘模型對水通道蛋白AQP3和AQP8的影響[J];世界華人消化雜志;2014年07期

6 謝培;周永學;;大鼠功能性便秘模型建立方法的研究[J];陜西中醫(yī);2014年03期

7 吳霜;孫桂東;陳玉根;吳本升;楊柏霖;;促結腸動力藥物治療慢性便秘的研究進展[J];世界華人消化雜志;2013年05期

8 鄒百倉;董蕾;李紅;王燕;趙剛;;5-HT_7受體對腸道運動的調節(jié)作用[J];西安交通大學學報(醫(yī)學版);2013年01期

9 楊勇軍;唐學貴;李梅;劉暢;李鐘艷;吳至久;何德才;田小兵;;通腑潤腸湯治療慢性功能性便秘的臨床療效研究[J];四川中醫(yī);2012年08期

10 包云光;李小兵;趙嬋;;復方苯乙哌啶對大鼠腸傳輸功能、病理和神經遞質的遠期影響[J];浙江醫(yī)學教育;2012年02期

相關博士學位論文 前1條

1 丁克;便秘文獻及方藥證治規(guī)律研究[D];山東中醫(yī)藥大學;2006年

相關碩士學位論文 前5條

1 譚義春;調臟舒秘湯對STC大鼠結腸ICC及血清SP、VIP影響的研究[D];川北醫(yī)學院;2016年

2 楊稀;中藥高位保留灌腸合腸道微生態(tài)制劑治療慢性功能性便秘的臨床及實驗研究[D];川北醫(yī)學院;2015年

3 胡強;中藥結腸高位灌腸合腹部外熨治療慢性功能性便秘的臨床及實驗研究[D];川北醫(yī)學院;2014年

4 葉詠梅;功能性便秘患者生物反饋治療依從性及其影響因素的研究[D];南京醫(yī)科大學;2009年

5 張海鵬;便秘病證的古今文獻研究與學術源流探討[D];北京中醫(yī)藥大學;2008年

，

本文編號：2144659